대학생의 대사증후군 위험요인과 혈청 요산 및 소변 내 산도와의 관련성

DOI QR코드

DOI QR Code

이진화;박현주
Lee, Jinhwa;Park, Hyunju

  • 투고 : 2013.10.20
  • 심사 : 2013.11.18
  • 발행 : 2013.11.30

초록

Purpose: A few Korean studies have reported that low urine acidity and hyperuricemia are related to metabolic syndrome. Therefore, we evaluated the relationships between urine pH, serum Uric Acid (UA), and metabolic risk factors in university students. Methods: Data were obtained from student health examinations in one university. Participants were 3,412 male and 4,214 female students. Descriptive statistics, t-test, logistic regressions and multiple logistic regression using SPSS version 18.0 were performed. Results: No significant relationship was found between metabolic risk factors and urine pH. From the univariate analysis, serum UA was significantly higher in obese ($BMI{\geq}25$), elevated blood pressure ($SBP{\geq}130$ and $DBP{\geq}85$), and higher triglyceride (${\geq}150$) groups for males and in obese, higher triglyceride and fasting blood sugar (${\geq}100$), and lower HDL-cholesterol (<50) groups for females. From the results of multivariate analysis, age, BMI, and triglyceride were significantly related to serum UA in males, BMI and HDL-cholesterol were significantly related to serum UA in females. Conclusion: Although there was no significant relationship between urinary pH and metabolic risk factors, significant associations between some of the metabolic risk factors and serum UA were found in the young adult population. Further studies are required to know the exact pathway between serum UA and metabolic syndrome.

키워드

혈청 요산;산도;대사증후군;대학생

참고문헌

  1. Abate, N., Chandalia, M., Cabo-Chan, A. V. Jr., Moe, O. W., & Sakhaee, K. (2004). The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney International, 65, 386-392. http://dx.doi.org/10.1111/j.1523-1755.2004.00386.x https://doi.org/10.1111/j.1523-1755.2004.00386.x
  2. Alverez-Lario, B., & Macarron-Vicente, J. (2010). Uric acid and evolution. Rheumatology, 49, 2010-2015. http://dx.doi.org/10.1093/rheumatology/keq204 https://doi.org/10.1093/rheumatology/keq204
  3. Burtis, C. A., & Ashwood, E. R. Tietz Textbook of Clinical Chemistry 2nd ed. Philadelphia: W. B. Saunders.
  4. Chang, I. H., Lee, Y. T., Lee, D. M., Kim, T. H., Myung, S. C, Kim, Y. D., et al. (2011). Metabolic syndrome, urine pH, and time-dependent risk of nephrolithiasis in Korean men without hypertension and diabetes. Endourology and Stones, 78, 753-758. http://dx.doi.org/10.1016/j.urology.2011.03,007
  5. Cho, S. T., Jung, S. I., Myung, S. C., & Kim, T. H. (2013). Correlation of metabolic syndrome with urinary stone composition. International Journal of Urology, 20, 208-213. http://dx.doi.org/doi: 10.1111/j.1442-2042.2012.03131.x https://doi.org/10.1111/j.1442-2042.2012.03131.x
  6. de Oliveira, E. P., & Burini, R. C., (2012). High plasma uric acid concentration: causes and consequences. Diabetology & Metabolic syndrome, 4, 4-12. http://dx.doi.org/10.1186/1758-5996-4-12 https://doi.org/10.1186/1758-5996-4-4
  7. Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005). The metabolic syndrome. Lancet, 365, 1415-28.http://dx.doi.org/10.1016/S0140-6736(09)61794-3 https://doi.org/10.1016/S0140-6736(05)66378-7
  8. Ervin, R. B. (2009). Prevalence of metabolic syndrome aming adults 20 years of age and over, by sex, age, race, and ethnicity, and body mass index: United States, 2003-3006. National Health Statistics Reports, 13, 1-8.
  9. Feig, D. I., & Johnson, R. J. (2003). Hyperuricemia in childhood primary hypertension. Hypertension, 4, 247-252. http://dx.doi.org/10.1161/01.HYP.0000085858. 66548.59 https://doi.org/10.1161/01.HYP.0000085858.66548.59
  10. Feig, D. I., Kang, D. H., & Johnson, R. J. (2008). Uric acid and cardiovascular risk. New England Journal of Medicine, 359, 1811-1121. http://dx.doi.org/10.1056/NEJMra0800885 https://doi.org/10.1056/NEJMra0800885
  11. Fernandez, A., Fuller, A., Al-Bareeq, R., Nott, L., & Razvi, H. (2013). A comparison of the metabolic profiles of diabetic and non-diabetic uric acid stone formers. Canadian Urological Association, 7(3-4), E190-192. http://dx.doi.org/10.5489/cuaj.11133 https://doi.org/10.5489/cuaj.820
  12. Ford, E. S., Giles, W. H., & Mokdad, A. H. (2004). Increasing prevalence of the metabolic syndrome among US. adults. Diabetes Care, 27, 2444-2449. https://doi.org/10.2337/diacare.27.10.2444
  13. Hara, S., Tsuji, H., Ohmoto, Y., Amakawa, K., Hsieh, S. D., Arase, Y., et al. (2012). High serum uric acid level and low urine pH as predictors of metabolic syndrome: a retrospective cohort study in a Japanese urban population. Metabolism, 61(2), 281-288. http://dx.doi.org/10.1016/j.metabol.2011.06.026 https://doi.org/10.1016/j.metabol.2011.06.026
  14. Hong, S. P., Lee, Y. S., Bae, K. R., Chung, J. W., Kim, S. Y, Lee, J. B., et al. (2008). Relationship between serum uric acid level and metabolic syndrome according to gender. Korean Circulation Journal, 38, 152-160. https://doi.org/10.4070/kcj.2008.38.3.152
  15. Ishiro, M., Takaya, R., Mori, Y., Takitani, K., Kono, Y., Okasora, K., et al. (2013). Association of uric acid with obesity and endothelial dysfunction in children and early adolescents. Annals of Nutrition & Metabolism, 62, 169-176. http://dx.doi.org/10.1159/000346227 https://doi.org/10.1159/000346227
  16. Johnson, R. J., Kang, D. H., Feig, D., Kivlighn, S., Kanellis, J., Watanabe, S., et al. (2003). Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension, 41, 1183-1190. http://dx.doi.org/10.1161/01.HYP.0000069700.62727.C5 https://doi.org/10.1161/01.HYP.0000069700.62727.C5
  17. Jung, T. S., Yang, W. J., & Song, Y. S. (2009). The correlation between metabolic syndrome and urinary pH in adult Korean men who visited a health promotion center. Korean Journal of Urology, 7, 694-698. http://dx.doi.org/10.4111/kju.2009. 50.7.694
  18. Lee, B. Y. (2008). The change of prevalence of metabolic syndrome and risk factors. Department of Health Policy and Hosipital Management, Unpublished master's thesis, Korea University, Seoul.
  19. Lee, H. M., Park, J. H., Kim, S. H., & Kim, J. Y. (2009). Association of the level of serum uric acid and metabolic syndrome in middle-aged women. Journal of Korean Society of Maternal and Child Health, 13, 182-194. https://doi.org/10.21896/jksmch.2009.13.2.182
  20. Liu, P. W., Chang, T. Y., & Chen, J. D. (2010). Serum uric acid and metabolic syndrome in Taiwanese adults. Metabolism, 59, 802-807. http://dx.doi.org/10.1016/j.metabol.2009.09.027 https://doi.org/10.1016/j.metabol.2009.09.027
  21. Maalouf, N. M. (2011). Metabolic syndrome and the genesis of uric acid stones. Journal of Renal Nutrition, 21(1), 128-131. http://dx.doi.org/10.1053/j.jrn.2010.10.015 https://doi.org/10.1053/j.jrn.2010.10.015
  22. Maalouf, N. M., Cameron, M. A., Moe, O. W., Adams-Huet, B., & Sakhaee, K. (2007). Low urine pH: a novel feature of the metabolic syndrome. American Society of Nephrology, 2, 883-888.http://dx.doi.org/10.2215/CJN.00670207 https://doi.org/10.2215/CJN.00670207
  23. Otsuki, M., Kitamura, T., Goya, K., Saito, H., Mukai, M., Kasayama, S., et al. (2011). Association of urine acidification with visceral obesity and the metabolic syndrome. Endocrine Journal, 58(5), 363-367. http://dx.doi.org/10.1507/endocrj.K10E-319. https://doi.org/10.1507/endocrj.K10E-319
  24. Park, H. S., Oh, S. W., Kang, J. H., Park, Y. W., Choi, J. M., Kim, Y. S., et al. (2003). Prevalence and associated factors with metabolic syndrome in South Korea: from the Korean National Health and Nutrition Examination Survey 1998. Journal of Korean Society for the Study of Obesity, 12(1), 1-14.
  25. Richette, P., & Bardin, T. (2010). Gout. Lancet, 375, 318-328. http://dx.doi.org/10.1016/S0140-6736(09)60883-7 https://doi.org/10.1016/S0140-6736(09)60883-7
  26. Richette, P., & Perez-Ruiz, F. (2013). Serum uric acid and metabolic risk. Current Medical Research & Opinion, 29(3), 9-15. http://dx.doi.org/10.1185/03007995.2013.790801 https://doi.org/10.1185/03007995.2013.790801
  27. Sakhaee, K., & Maalouf, N. M. (2008). Metabolic syndrome and uric acid nephrolithiasis. Seminars in Nephrology, 28(2), 174-180. http://dx.doi.org/10.1016/j.semnephrol https://doi.org/10.1016/j.semnephrol.2008.01.010
  28. Singh, A. S., Mulder, C., Twisk, J. W. R., Van Mechelen, W., & Chinapaw, M. J. M. (2008) Tracking of childhood overweight into adulthood: a systematic review of the literature. Obesity Review, 9, 474-488. http://dx.doi.org/10.1111/j.1467-789x.2008.00475.x https://doi.org/10.1111/j.1467-789X.2008.00475.x
  29. Stamatelou, K. K., Francis, M. E., Jones, C. A., Nyberg, L., M., & Curhan, G. C. (2003). Time trends in reported prevalence of kidney stone in the United States: 1976-1994. Kidney International, 63, 1817-1823. http://dx.doi.org/10.1046/j. 1523-1755.2003.00917.x https://doi.org/10.1046/j.1523-1755.2003.00917.x
  30. Stewart, P. M. (2008). The adrenal cortex, corticosteroid hormone action. In Kronenberg, H. M., Melmed, S., Polonsky, K. S., Karsen, P. R. (Ed.), Williams Textbook of Endocrinology, 11th ed(pp. 453-464). Philadelphia, PA: Elsevier Health Sciences.
  31. Yoo, T. W., Sung, K. C., Kim, Y. C., Hwang, S. T., Oh, S. Y., Shin, H. S., et al. (2004). The relationship of the hypertension, insulin resistance, and metabolic syndrome in the serum uric acid level. Korean Circulation Journal, 34, 874-882. https://doi.org/10.4070/kcj.2004.34.9.874